probenecid has been researched along with Cerebral Pseudosclerosis in 1 studies
Probenecid: The prototypical uricosuric agent. It inhibits the renal excretion of organic anions and reduces tubular reabsorption of urate. Probenecid has also been used to treat patients with renal impairment, and, because it reduces the renal tubular excretion of other drugs, has been used as an adjunct to antibacterial therapy.
probenecid : A sulfonamide in which the nitrogen of 4-sulfamoylbenzoic acid is substituted with two propyl groups.
Excerpt | Relevance | Reference |
---|---|---|
"Wilson's disease is an inherited, autosomal recessive disorder of copper accumulation and toxicity." | 1.34 | Down-regulation of intestinal multidrug resistance-associated protein 2 in long-evans cinnamon rats. ( Chiba, M; Hirano, T; Iseki, K; Itagaki, S; Kobayashi, M, 2007) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chiba, M | 1 |
Itagaki, S | 1 |
Kobayashi, M | 1 |
Hirano, T | 1 |
Iseki, K | 1 |
1 other study available for probenecid and Cerebral Pseudosclerosis
Article | Year |
---|---|
Down-regulation of intestinal multidrug resistance-associated protein 2 in long-evans cinnamon rats.
Topics: Animals; ATP-Binding Cassette Transporters; Disease Models, Animal; Down-Regulation; Hepatolenticula | 2007 |